You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Medtronic knows how committed you are to helping patients manage their health. We share your commitment with a passion for providing lifelong solutions that can assist you in managing patients' chronic medical conditions. Our products range from diagnostic equipment to therapies that manage long-term conditions where other medical therapies have failed.
In continuing to this website, you acknowledge you are a registered healthcare professional and I have a valid certification in your possession.
By clicking 'Accept' below you agree that you are a registered healthcare professional and you have a valid certification in your possession.
Brett Wall is Executive Vice President and President of Medtronic’s Neuroscience Portfolio that is comprised of five unique Operating Units—Neuromodulation, Cranial & Spinal Technologies, Neurovascular, Pelvic Health and Ear, Nose and Throat. Together, these Operating Units generate over $8B in annual revenue and employ approximately 15,000 employees worldwide. Brett also serves as a member of the company’s Executive Committee.
Previously, he was Senior Vice President of the legacy Brain Therapies division which is part of the Neuroscience portfolio.
Brett also serves as the Executive Sponsor of the Medtronic African Descent Network — an internal national resource group that focuses on recruitment, engagement, retention and development for employees of African descent.
Prior to the Medtronic acquisition of Covidien, Brett served as Covidien President, Neurovascular and International, where he managed all commercial activities and functions of the business resulting in a doubling of revenue during his tenure.
He also served as Senior Vice President and President, Neurovascular; and Senior Vice President and President, International, at ev3, Inc. Prior to the ev3 merger with Micro Therapeutics, Brett held the positions of Micro Therapeutic Vice President, Marketing, for the Neurovascular and Peripheral Vascular divisions.
Brett’s career journey also included work at Boston Scientific as the Director of Marketing, Cardiovascular, Asia Pacific; and Marketing Manager, Japan, where he was responsible for the Interventional Cardiology product lines within the Asia-Pacific region. In addition, he held positions of increasing responsibility at C.R. Bard, where he was responsible for marketing the company’s suite of urological products.
Brett currently serves on the board executive committee for OCTANe, a group that promotes technical growth and expertise in the greater Orange County, California area. He also is a member of the CEO Roundtable at the University of California, Irvine. Previously, Brett served as Chairman of the Heart and Stroke Ball for the American Heart Association, Orange County Chapter.
Brett earned his bachelor’s degree in Comprehensive Business Administration with an emphasis in Marketing from the University of Nebraska at Kearney. He is a resident of Southern California.
This information is designed to provide you with helpful educational information but is for information purposes only, is not medical advice, and should not be used as an alternative to speaking with your doctor. No representation is made that the information provided is current, complete, or accurate. Medtronic does not assume any responsibility for persons relying on the information provided. Be sure to discuss questions specific to your health and treatments with a healthcare professional. For more information please speak to your healthcare professional.